vs

Side-by-side financial comparison of Cognizant (CTSH) and TELUS CORP (TU). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.3B vs $3.7B, roughly 1.4× TELUS CORP). Cognizant runs the higher net margin — 12.2% vs -4.8%, a 17.0% gap on every dollar of revenue. On growth, Cognizant posted the faster year-over-year revenue change (4.9% vs 2.2%).

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

Telus Corporation is a Canadian publicly traded holding company and conglomerate, headquartered in Vancouver, British Columbia, which is the parent company of several subsidiaries: Telus Communications offers telephony, television, data and Internet services; Telus Mobility offers wireless services; Telus Health operates companies that provide health products and services; and Telus Digital operates worldwide, providing multilingual customer service outsourcing and digital IT services. Telus ...

CTSH vs TU — Head-to-Head

Bigger by revenue
CTSH
CTSH
1.4× larger
CTSH
$5.3B
$3.7B
TU
Growing faster (revenue YoY)
CTSH
CTSH
+2.8% gap
CTSH
4.9%
2.2%
TU
Higher net margin
CTSH
CTSH
17.0% more per $
CTSH
12.2%
-4.8%
TU

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CTSH
CTSH
TU
TU
Revenue
$5.3B
$3.7B
Net Profit
$648.0M
$-178.8M
Gross Margin
90.2%
Operating Margin
16.0%
3.4%
Net Margin
12.2%
-4.8%
Revenue YoY
4.9%
2.2%
Net Profit YoY
18.7%
-210.9%
EPS (diluted)
$1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSH
CTSH
TU
TU
Q4 25
$5.3B
Q3 25
$5.4B
Q2 25
$5.2B
$3.7B
Q1 25
$5.1B
Q4 24
$5.1B
Q3 24
$5.0B
Q2 24
$4.8B
$3.6B
Q1 24
$4.8B
Net Profit
CTSH
CTSH
TU
TU
Q4 25
$648.0M
Q3 25
$274.0M
Q2 25
$645.0M
$-178.8M
Q1 25
$663.0M
Q4 24
$546.0M
Q3 24
$582.0M
Q2 24
$566.0M
$161.3M
Q1 24
$546.0M
Gross Margin
CTSH
CTSH
TU
TU
Q4 25
Q3 25
Q2 25
90.2%
Q1 25
Q4 24
Q3 24
Q2 24
87.9%
Q1 24
Operating Margin
CTSH
CTSH
TU
TU
Q4 25
16.0%
Q3 25
16.0%
Q2 25
15.6%
3.4%
Q1 25
16.7%
Q4 24
14.8%
Q3 24
14.6%
Q2 24
14.6%
13.7%
Q1 24
14.6%
Net Margin
CTSH
CTSH
TU
TU
Q4 25
12.2%
Q3 25
5.1%
Q2 25
12.3%
-4.8%
Q1 25
13.0%
Q4 24
10.7%
Q3 24
11.5%
Q2 24
11.7%
4.4%
Q1 24
11.5%
EPS (diluted)
CTSH
CTSH
TU
TU
Q4 25
$1.35
Q3 25
$0.56
Q2 25
$1.31
Q1 25
$1.34
Q4 24
$1.10
Q3 24
$1.17
Q2 24
$1.14
Q1 24
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSH
CTSH
TU
TU
Cash + ST InvestmentsLiquidity on hand
$1.9B
$2.7B
Total DebtLower is stronger
Stockholders' EquityBook value
$15.0B
$11.8B
Total Assets
$20.7B
$44.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSH
CTSH
TU
TU
Q4 25
$1.9B
Q3 25
$2.4B
Q2 25
$1.8B
$2.7B
Q1 25
$2.0B
Q4 24
$2.2B
Q3 24
$2.0B
Q2 24
$2.2B
$676.7M
Q1 24
$2.2B
Stockholders' Equity
CTSH
CTSH
TU
TU
Q4 25
$15.0B
Q3 25
$14.9B
Q2 25
$15.3B
$11.8B
Q1 25
$14.9B
Q4 24
$14.4B
Q3 24
$14.5B
Q2 24
$13.9B
$12.4B
Q1 24
$13.5B
Total Assets
CTSH
CTSH
TU
TU
Q4 25
$20.7B
Q3 25
$20.1B
Q2 25
$20.2B
$44.3B
Q1 25
$20.0B
Q4 24
$20.0B
Q3 24
$20.2B
Q2 24
$18.6B
$41.8B
Q1 24
$18.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSH
CTSH
TU
TU
Operating Cash FlowLast quarter
$858.0M
$851.2M
Free Cash FlowOCF − Capex
$781.0M
FCF MarginFCF / Revenue
14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
1.32×
TTM Free Cash FlowTrailing 4 quarters
$2.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSH
CTSH
TU
TU
Q4 25
$858.0M
Q3 25
$1.2B
Q2 25
$398.0M
$851.2M
Q1 25
$400.0M
Q4 24
$920.0M
Q3 24
$847.0M
Q2 24
$262.0M
$1.0B
Q1 24
$95.0M
Free Cash Flow
CTSH
CTSH
TU
TU
Q4 25
$781.0M
Q3 25
$1.2B
Q2 25
$331.0M
Q1 25
$323.0M
Q4 24
$837.0M
Q3 24
$791.0M
Q2 24
$183.0M
Q1 24
$16.0M
FCF Margin
CTSH
CTSH
TU
TU
Q4 25
14.6%
Q3 25
21.4%
Q2 25
6.3%
Q1 25
6.3%
Q4 24
16.5%
Q3 24
15.7%
Q2 24
3.8%
Q1 24
0.3%
Capex Intensity
CTSH
CTSH
TU
TU
Q4 25
1.4%
Q3 25
1.2%
Q2 25
1.3%
Q1 25
1.5%
Q4 24
1.6%
Q3 24
1.1%
Q2 24
1.6%
Q1 24
1.7%
Cash Conversion
CTSH
CTSH
TU
TU
Q4 25
1.32×
Q3 25
4.48×
Q2 25
0.62×
Q1 25
0.60×
Q4 24
1.68×
Q3 24
1.46×
Q2 24
0.46×
6.28×
Q1 24
0.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSH
CTSH

Health Sciences$1.4B25%
Financial Services$1.1B21%
Consulting And Technology Services$944.0M18%
Productsand Resources$921.0M17%
Outsourcing Services$677.0M13%
Transaction Or Volume Based$308.0M6%

TU
TU

Segment breakdown not available.

Related Comparisons